1194 - Single dose stereotactic radiosurgery for benign and malignant intracranial tumours

Page last updated: 11/10/2016

Application Detail



Description of Medical Service

Single dose stereotactic radiosurgery delivers focused radiation beams to targets in the brain. 201 individual radiation sources (cobalt 60) are positioned in a hemisphere so that the beams converge at a single focal point. The shape of the dose distribution is planned so at to cover the target, while aiming to minimise the effect on the surrounding healthy tissue.

Description of Medical Condition

Stereotactic radiosurgery is intended to treat malignant and benign intracranial conditions. The specific indications are:
  1. cerebral metastases
  2. arteriovenous malformations (AVMs)
  3. benign intracranial tumours
    1. acoustic neuroma
    2. meningioma
    3. pituitary tumours
  4. primary malignant intracranial tumours.

Reason for Application


Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

13 December 2012
Final Decision Analytic Protocol (DAP) (PDF 782 KB)
Final Decision Analytic Protocol (DAP) (Word 1223 KB)

Assessment Report


Public Summary Document

1194 - Public Summary Document (PDF 885 KB)
1194 - Public Summary Document (Word 605 KB)

Meetings for this Application


16 to 17 August 2012
13 December 2012


12 to 13 June 2014
11 to 12 June 2015


30 to 31 July 2015